Web Images Videos Maps News Shopping Gmail more »
Sign in
Scholar Home  
  Advanced Scholar Search
Scholar Preferences
Scholar Results 1 - 10 of about 508 citing Yoshida: Interferon therapy reduces the risk for hepatocellular carcinoma: national surveillance.... (0.09 sec) 

[PDF] Diagnosis, management, and treatment of hepatitis C


DB Strader, T Wright, DL Thomas, LB Seeff… - Hepatology, 2004 - texasliver.com
These recommendations provide a data-supported approach. They are based on the
following: (1) a formal review and analysis of the recently-published world
literature on the topic [Medline search]; (2) the American College of ...
Cited by 1062 - Related articles - View as HTML - All 11 versions

Impact of pegylated interferon alfa-2b and ribavirin on liver fibrosis in patients with chronic …

- natap.org [PDF] 
T Poynard, J McHutchison, M Manns, C Trepo, … - Gastroenterology, 2002 - Elsevier
Necrosis and inflammation improvement ranged from 39% (interferon 24 weeks) to
73% (optimized PEG 1.5 and ribavirin; P < 0.001). Fibrosis worsening ranges from
23% (interferon 24 weeks) to 8% (optimized PEG 1.5 and ribavirin; P < ...
Cited by 528 - Related articles - BL Direct - All 17 versions

Recovery, persistence, and sequelae in hepatitis C virus infection: a perspective on long- …

- washington.edu [PDF] 
HJ Alter, LB Seeff - Seminars in Liver Disease, 2000 - thieme-connect.com
Hepatitis C has emerged in recent years as the most common basis for liver
disease in the United States, having infected an estimated 3.9 million people in
this country and an estimated 170 million worldwide. Currently, it is the ...
Cited by 459 - Related articles - BL Direct - All 7 versions

Viral hepatitis C

- temple.edu [PDF] 
T Poynard, MF Yuen, V Ratzin, CL Lai - The Lancet, 2003 - Elsevier
More than 170 million people worldwide are chronically infected with the
hepatitis C virus (HCV), which is responsible for more than 100 000 cases of
liver cancer per year, with similar numbers of digestive haemorrhage and ...
Cited by 375 - Related articles - All 11 versions

Hepatocellular carcinoma-cause, treatment and metastasis


ZY Tang - World Journal of Gastroenterology, 2001 - wjgnet.com
In the recent decades, the incidence of hepatocellular carcinoma (HCC) has been
found to be increasing in males in some countries. In China, HCC ranked second
of cancer mortality since 1990s. Hepatitis B and C viruses (HBV and HCV) ...
Cited by 371 - Related articles - Cached - BL Direct - All 13 versions

Hepatocellular carcinoma in cirrhosis: incidence and risk factors


G Fattovich, T Stroffolini, I Zagni, F Donato - Gastroenterology, 2004 - Elsevier
Emerging data indicate that the mortality rate of hepatocellular carcinoma (HCC)
associated with cirrhosis is rising in some developed countries, whereas
mortality from non-HCC complications of cirrhosis is decreasing or is ...
Cited by 341 - Related articles - BL Direct - All 15 versions

Retinoids in cancer chemoprevention


M Okuno, S Kojima, R Matsushima-Nishiwaki, … - Current Cancer Drug Targets, 2004 - ingentaconnect.com
Page 1. Current Cancer Drug Targets, 2004, 4, 285-298 285 1568-0096/04 $45.00+.00 ©
2004 Bentham Science Publishers Ltd. Retinoids in Cancer Chemoprevention ...
Cited by 247 - Related articles - BL Direct - All 2 versions

Hepatocellular carcinoma: an epidemiologic view


HB El-Serag - Journal of clinical gastroenterology, 2002 - journals.lww.com
Hepatocellular carcinoma (HCC) is the fifth most common malignancy in the world
and is estimated to cause approximately half a million deaths annually. Because
of its high fatality rates, the incidence and mortality rates are almost ...
Cited by 245 - Related articles - BL Direct - All 5 versions

[PDF] Hepatocellular carcinoma and hepatitis C in the United States


HB El-Serag… - Hepatology, 2002 - sadieo.ucsf.edu
Chronic infection with hepatitis C virus (HCV) is a major risk factor for
development of hepatocellular carcinoma (HCC). In general, HCC develops only
after 2 or more decades of HCV infection and the increased risk is ...
Cited by 238 - Related articles - View as HTML - BL Direct - All 7 versions

Risk factors for the rising rates of primary liver cancer in the United States

- va.gov [PDF] 
HB El-Serag, AC Mason - Archives of Internal Medicine, 2000 - Am Med Assoc
You are seeing this message because your Web browser does not support basic Web
standards. Find out more about why this message is appearing and what you can do
to make your experience on this site better. ... Add to CiteULike Add to ...
Cited by 223 - Related articles - BL Direct - All 5 versions


Result Page: 

1

2

3

4

5

6

7

8

9

10

Next


 


Go to Google Home - About Google - About Google Scholar

©2009 Google